Another study reported class II histone deacetylases (HDACs) as co-ordinators of HSP-mediated VEGFR regulation; interestingly, treatment of cancer cell lines with a HDAC inhibitor decreased HSP90 binding, but increased HSP70 binding to VEGFR2 [39]. Here, HSP90AB1 is linked to cancer.